Evidence for Functional Heterogeneity of Circulating B-Type Natriuretic Peptide

Journal of the American College of Cardiology

Volumn 49, Issue 10, 2007, Pages 1071-1078

  Liang, Faquan ^a   O'Rear, Jessica ^a   Schellenberger, Ute ^a   Tai, Lungkuo ^a   Lasecki, Michael ^a   Schreiner, George F ^a   Apple, Fred S ^b   Maisel, Alan S ^c   Pollitt, N Stephen ^a   Protter, Andrew A ^a  

^a SCIOS INC   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ARTICLE; BIOLOGICAL ACTIVITY; CELL ACTIVITY; CONTROLLED STUDY; DEGLYCOSYLATION; HEART FAILURE; HORMONE ACTION; HORMONE BLOOD LEVEL; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

BIOLOGICAL MARKERS; BLOTTING, WESTERN; CELLS, CULTURED; DISEASE PROGRESSION; DNA, COMPLEMENTARY; DOWN-REGULATION; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; HEART FAILURE, CONGESTIVE; HUMANS; IMMUNOPRECIPITATION; MOLECULAR BIOLOGY; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; SENSITIVITY AND SPECIFICITY;

EID: 33847358624     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.10.063     Document Type: Article

References (30)

1. Levin E.R., Gardner D.G., and Samson W.K. Natriuretic peptides. N Engl J Med 339 (1998) 321-328
2. Seilhamer J.J., Arfsten A., Miller J.A., et al. Human and canine gene homologs of porcine brain natriuretic peptide. Biochem Biophys Res Commun 165 (1989) 650-658
3. Goetze J.P. Biochemistry of pro-B-type natriuretic peptide-derived peptides: the endocrine heart revisited. Clin Chem 50 (2004) 1503-1510
4. Hino J., Tateyama H., Minamino N., Kangawa K., and Matsuo H. Isolation and identification of human brain natriuretic peptides in cardiac atrium. Biochem Biophys Res Commun 167 (1990) 693-700
5. Ma K.K., Banas K., and de Bold A.J. Determinants of inducible brain natriuretic peptide promoter activity. Regul Pept 128 (2005) 169-176
6. Hasegawa K., Fujiwara H., Doyama K., et al. Ventricular expression of brain natriuretic peptide in hypertrophic cardiomyopathy. Circulation 88 (1993) 372-380
7. Mukoyama M., Nakao K., Saito Y., et al. Increased human brain natriuretic peptide in congestive heart failure. N Engl J Med 323 (1990) 757-758
8. Nakagawa O., Ogawa Y., Itoh H., et al. Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload. J Clin Invest 96 (1995) 1280-1287
9. Rodeheffer R.J. Measuring plasma B-type natriuretic peptide in heart failure: good to go in 2004?. J Am Coll Cardiol 44 (2004) 740-749
10. Maisel A.S., Krishnaswamy P., Nowak R.M., et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347 (2002) 161-167
11. de Lemos J.A., Morrow D.A., Bentley J.H., et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 345 (2001) 1014-1021
12. Berger R., Huelsman M., Strecker K., et al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation 105 (2002) 2392-2397
13. Goetze J.P., Kastrup J., and Rehfeld J.F. The paradox of increased natriuretic hormones in congestive heart failure patients: does the endocrine heart also fail in heart failure?. Eur Heart J 24 (2003) 1471-1472
14. Tateyama H., Hino J., Minamino N., et al. Concentrations and molecular forms of human brain natriuretic peptide in plasma. Biochem Biophys Res Commun 185 (1992) 760-767
15. Yandle T.G., Richards A.M., Gilbert A., Fisher S., Holmes S., and Espiner E.A. Assay of brain natriuretic peptide (BNP) in human plasma: evidence for high molecular weight BNP as a major plasma component in heart failure. J Clin Endocrinol Metab 76 (1993) 832-838
16. Giuliani I., Rieunier F., Larue C., et al. Assay for measurement of intact B-type natriuretic peptide prohormone in blood. Clin Chem 52 (2006) 1054-1061
17. Shimizu H., Masuta K., Aono K., et al. Molecular forms of human brain natriuretic peptide in plasma. Clin Chim Acta 316 (2002) 129-135
18. Hawkridge A.M., Heublein D.M., Bergen III H.R., Cataliotti A., Burnett Jr. J.C., and Muddiman D.C. Quantitative mass spectral evidence for the absence of circulating brain natriuretic peptide (BNP-32) in severe human heart failure. Proc Natl Acad Sci U S A 102 (2005) 17442-17447
19. Kuhn M. Molecular physiology of natriuretic peptide signaling. Basic Res Cardiol 99 (2004) 76-82
20. Sabrane K., Kruse M.N., Fabritz L., et al. Vascular endothelium is critically involved in the hypotensive and hypovolemic actions of atrial natriuretic peptide. J Clin Invest 115 (2005) 1666-1674
21. Protter A.A., Wallace A.M., Ferraris V.A., and Weishaar R.E. Relaxant effect of human brain natriuretic peptide on human artery and vein tissue. Am J Hypertens 9 (1996) 432-436
22. Holtwick R., Gotthardt M., Skryabin B., et al. Smooth muscle-selective deletion of guanylyl cyclase-A prevents the acute but not chronic effects of ANP on blood pressure. Proc Natl Acad Sci U S A 99 (2002) 7142-7147
23. Schellenberger U., O'Rear J., Guzzetta A., Jue R.A., Protter A.A., and Pollitt N.S. The precursor to B-type natriuretic peptide is an O-linked glycoprotein. Arch Biochem Biophys 451 (2006) 160-166
24. Shimizu H., Masuta K., Asada H., Sugita K., and Sairenji T. Characterization of molecular forms of probrain natriuretic peptide in human plasma. Clin Chim Acta 334 (2003) 233-239
25. Zhou H.L., and Fiscus R.R. Brain natriuretic peptide (BNP) causes endothelium-independent relaxation and elevation of cyclic GMP in rat thoracic aorta. Neuropeptides 14 (1989) 161-169
26. Liang F., Wu J., Garami M., and Gardner D.G. Mechanical strain increases expression of the brain natriuretic peptide gene in rat cardiac myocytes. J Biol Chem 272 (1997) 28050-28056
27. Almeida F.A., Suzuki M., Scarborough R.M., Lewicki J.A., and Maack T. Clearance function of type C receptors of atrial natriuretic factor in rats. Am J Physiol 256 (1989) R469-R475
28. Nussenzveig D.R., Lewicki J.A., and Maack T. Cellular mechanisms of the clearance function of type C receptors of atrial natriuretic factor. J Biol Chem 265 (1990) 20952-20958
29. Almirez R., and Protter A.A. Clearance of human brain natriuretic peptide in rabbits; effect of the kidney, the natriuretic peptide clearance receptor, and peptidase activity. J Pharmacol Exp Ther 289 (1999) 976-980
30. Apple F.S., Panteghini M., Ravkilde J., et al. Quality specifications for B-type natriuretic peptide assays. Clin Chem 51 (2005) 486-493